CDERLearn Training and Education
Learning opportunities for healthcare professionals, academia, students, and consumers
Search General Courses Search Industry Courses
Upcoming Free CE Opportunities
- December 13, 2022: FDA Drug Topics: Frequently Asked Questions about Labeling for Prescription Medicines
- December 14, 2022: What to Expect after an Inspection: 483s, Responses and Beyond
Summary | Type | Topic |
---|---|---|
Biosimilars in the Real World: Perspectives for Staying Within the Scope of Care | CE Credits; Health Care Professionals; Case Study; Podcasts; Videos; Webinars | Biosimilars; Cancer Drugs; Diabetes; Disease States; Drug Regulatory Process; Drug Development; Drug Safety; Generic Drugs; MedWatch |
Pregnancy and Lactation Medication Information for the Healthcare Provider: | Health Care Professionals; Patients; Webinars | Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; MedWatch; Women's Health |
Leveraging Real-World Data to Study Medication Use in Pregnancy and Lactation | Health Care Professionals; Patients; Webinars | Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; MedWatch; Women's Health |
CBD and Other Cannabinoids: Sex and Gender Differences in Use and Responses | Health Care Professionals; Patients; Webinars | Cancer Drugs; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; MedWatch; Opioids; Women's Health |
Opioid and Nicotine Use, Dependence, and Recovery: Influences of Sex and Gender | Health Care Professionals; Patients; Webinars | Cancer Drugs; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; MedWatch; Opioids; Women's Health |
Maximizing Benefits and Minimizing Harms from Antibiotics | Health Care Professionals; Patients; Webinars | Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; MedWatch |
Health Fraud Scams | Health Care Professionals; Patients; Podcasts; Videos | COVID-19; Disease States; Drug Regulatory Process; Drug Development; Drug Safety; MedWatch; Generic Drugs |
Learn Six Tip-Offs to Rip-Offs: Don't Fall for Health Fraud Scams | Health Care Professionals; Patients; Podcasts; Videos | COVID-19; Disease States; Drug Regulatory Process; Drug Development; Drug Safety; MedWatch; Generic Drugs |
BeSafeRx: Your Source for Online Pharmacy Information | Health Care Professionals; Patients; Podcasts; Videos | COVID-19; Disease States; Drug Regulatory Process; Drug Development; Drug Safety; MedWatch; Generic Drugs |
Health Care Professionals; Patients; Podcasts; Videos | COVID-19; Disease States; Drug Regulatory Process; Drug Development; Drug Safety; MedWatch | |
FDA’s Overdose Prevention Framework with Dr. Marta Sokolowska | Health Care Professionals; Patients; Podcasts | Disease States; Drug Regulatory Process; Drug Development; Drug Safety; MedWatch; Opioids; Cancer Drugs |
FDA Health Playbook | Health Care Professionals; Patients; Videos; Graphics; Podcasts; Social Media | Drug Safety; OTC Drug Regulations; MedWatch; Opioids |
COVID-19 Evidence Accelerator: What We've Learned, Where We're Headed | Health Care Professionals; Patients; Webinars | COVID-19; Disease States; Drug Regulatory Process; Drug Development; Drug Safety |
14th Annual Sentinel Initiative Public Workshop | Health Care Professionals; Patients; Webinars | COVID-19; Disease States; Drug Regulatory Process; Drug Development; Drug Safety |
Medical Extended Reality: Applications and Challenges | Health Care Professionals; Patients; Webinars | Disease States; Drug Regulatory Process; Drug Development; Drug Safety |
Highlights in Oncofertility: Trends in an Emerging Field for Cancer Survivors |
Health Care Professionals; Patients; Webinars | Cancer Drugs; Disease States; Drug Regulatory Process; Drug Development; Drug Safety; Women’s Health |
What does FDA regulate? | Health Care Professionals; Patients; Videos; Graphics | Disease States; Drug Regulatory Process; Drug Development; Drug Safety; Generic Drugs; OTC Drug Regulations; Women’s Health |
FDA Grand Rounds | Health Care Professionals; Patients; Webinars | COVID-19; Disease States; Drug Regulatory Process; Drug Development; Drug Safety; MedWatch; Generic Drugs; OTC Drug Regulations; Biosimilars; IND; Cancer Drugs; Biomarker; Women’s Health |
Safe Opioid Disposal | Safe Opioid Disposal - Remove the Risk Outreach Toolkit | Disease States; Drug Regulatory Process; Drug Development; Drug Safety; MedWatch; Generic Drugs; Cancer Drugs; Opioids |
What Does FDA Do? | Health Care Professionals; Patients; Videos | Disease States; Drug Regulatory Process; Drug Development; Drug Safety; MedWatch; Generic Drugs; OTC Drug Regulations; IND; Women’s Health |
COVID-19 Evidence Accelerator: What We've Learned, Where We're Headed |
Type: Health Care Professionals; Patients; Videos | Topic: COVID-19; Disease States; Drug Regulatory Process; Drug Development; Drug Safety; IND; Cancer Drugs |
Conversation on Paxlovid with Dr. John Farley | Health Care Professionals; Patients; Podcasts | COVID-19; Disease States; Drug Regulatory Process; Drug Development; Drug Safety |
Clinical Trial Basics with Dr. Robert Temple | Health Care Professionals; Patients; Podcasts | Disease States; Drug Regulatory Process; Drug Development; Drug Safety; IND; Biomarker; Women’s Health |
Biosimilars Patient Materials | Graphics; Videos; Patients | Biosimilars; Drug Regulatory Process; Drug Development; Disease States; Drug Safety |
Clinical Trial Basics | Health Care Professionals; Podcasts | Biomarkers; Disease States; Drug Regulatory Process; Drug Development; Drug Safety; IND; Women’s Health |
Adverse Events Associated with Compounded Drugs from Outsourcing Facilities | Health Care Professionals; Case Study; Podcasts; Videos; Webinars | Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; MedWatch |
Biosimilars 101: A Primer for Your Practice | CE Credits; Health Care Professionals; Case Study | Biosimilars; Cancer Drugs; Diabetes; Disease States; Drug Regulatory Process; Drug Development; Drug Safety; Generic Drugs; MedWatch; Women’s Health |
Incorporating Biosimilars Into the Management of Patients With Immunological Conditions | CE Credits; Health Care Professionals; Case Study | Biosimilars; Cancer Drugs; Diabetes; Disease States; Drug Regulatory Process; Drug Development; Drug Safety; Generic Drugs; MedWatch; Women’s Health |
Putting the Patient into Perspective: Strategies for Educating Patients about Biosimilars | CE Credits; Health Care Professionals; Case Study; Podcasts; Videos; Webinars | Biosimilars; Cancer Drugs; Diabetes; Disease States; Drug Regulatory Process; Drug Development; Drug Safety; Generic Drugs; MedWatch; Women’s Health |
Biosimilars Resources | Health Care Professionals; Case Study; Podcasts; Videos; Webinars | Biosimilars; Drug Regulatory Process; Drug Development |
Bridging Efficacy and Safety to the Obese | Health Care Professionals; Webinars | Biomarker; Cancer Drugs; Diabetes; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; IND; MedWatch; Women's Health |
Engaging Providers to Address Knowledge Gaps on Medication Use in Pregnancy and Lactation | CE Credits; Health Care Professionals; Webinars | Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; MedWatch; Women's Health |
Biosimilars Videos | Healthcare Professionals; Videos Biosimilars; Drug Regulatory Process | Drug Development |
Biosimilars Level 2: Regulatory and Scientific Concepts | Case Study | Health Care Professionals |
Biosimilars Level 1: Foundational Concepts | Case Study | Health Care Professionals |
Increasing the Efficiency of Biosimilar Development Programs | Health Care Professionals; Webinars | Biosimilars; Drug Regulatory Process; Drug Development |
Successfully Navigating the USPTO and FDA | CE Credits; Webinars | Drug Development; Drug Regulatory Process; Drug Safety; Registration and Listing |
The History of FDA | Health Care Professionals; Webinars | Drug Development; Drug Regulatory Process; Drug Safety |
Bench to Bedside: Integrating Sex and Gender to Improve Human Health | CE Credits; Health Care Professionals; Webinars | Diabetes; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Women's Health |
Q&A with FDA | Health Care Professionals; Podcasts | COVID-19; Disease States; Drug Regulatory Process; Drug Development; Drug Safety; MedWatch |
Biosimilars Level 1: Foundational Concepts | Health Care Professionals; Case Study | Biosimilars; Drug Regulatory Process; Drug Development |
Biosimilars Level 2: Regulatory and Scientific Concepts | Health Care Professionals; Case Study | Biosimilars; Drug Regulatory Process; Drug Development |
Biosimilars Curriculum Materials | Health Care Professionals; Case Study; Podcasts; Videos; Webinars | Biosimilars; Drug Regulatory Process; Drug Development |
Drug Approval Case Studies | Health Care Professionals | Drug Regulatory Process |
FDA’s Role in Public Health: Drug Efficacy, Safety, Quality, and Beyond | Health Care Professionals; CE Credits | Drug Regulatory Process |
Practitioners’ Guide for Improving Oral Anticoagulant Use | Health Care Professionals; CE Credits | Oral Anticoagulant; Disease States |
The FDA Bad Ad Program and Prescription Drug Promotion | Health Care Professionals; CE Credits | Prescription Drug Promotion |
FDA MedWatch and Patient Safety | Health Care Professionals | MedWatch; Drug Safety |
The FDA Process for Approving Generic Drugs | Health Care Professionals | Drug Regulatory Process; Drug Development; Generic Drugs |
FDA Overview of Biosimilar Products | Health Care Professionals; Videos | Biosimilars; Drug Regulatory Process; Drug Development |
Leveraging Health Literacy and Patient Preferences to Reduce Hypoglycemia Events in Patients with Type 2 Diabetes | Health Care Professionals | Diabetes; Disease States |
Director's Corner Podcasts | Health Care Professionals; Podcasts | Drug Regulatory Process; Drug Development; Compounding; Generic Drugs; Drug Safety; MedWatch; Disease States |
Drug Information Soundcast in Clinical Oncology (D.I.S.C.O) | Health Care Professionals; Podcasts | Cancer Drugs; Disease States; Drug Regulatory Process; Drug Development; Drug Safety; Generic Drugs; MedWatch; Women’s Health |
FDA Drug Safety Podcasts | Health Care Professionals; Podcasts | Drug Safety; Biosimilars; Cancer Drugs; Diabetes; Disease States; Drug Regulatory Process; Drug Development; Drug Safety; Generic Drugs; MedWatch; Women’s Health |
Regulatory Science at CDER Podcasts | Health Care Professionals; Podcasts | Drug Development; Disease States; Drug Regulatory Process; Drug Safety; IND |
FDA's Biomarker Qualification Program | Videos | Biomarker; Drug Development |
Biosimillars Health Care Provider Materials | Health Care Professionals; Videos; Graphics; Social Media | Biosimilars; Drug Regulatory Process; Drug Development; Disease States; Drug Safety |
FDA Drug Info Rounds | Health Care Professionals; Videos | Drug Safety; MedWatch; IND; Drug Development; Drug Regulatory Process; Prescription Drug Promotion; Disease States; Registration and Listing; Generic Drugs |
GDUFA II Videos and Resources | Videos | Drug Development; Generic Drugs |
Regulatory Science at CDER Videos | Videos | Drug Regulatory Process; Drug Development |
Biosimilars Online Courses, Webinars, and Presentations | Health Care Professionals; Webinars | Biosimliars; Drug Regulatory Process; Drug Development |
CDER Webinars | Health Care Professionals; Webinars | Drug Regulatory Process; Drug Development; Generic Drugs; OTC Drug Regulations; Registration and Listing; Electronic Submissions; Biosimilars; Drug Safety; MedWatch; IND; Disease States; Prescription Drug Promotion; Cancer Drugs |
Division of Drug Information Webinars | Health Care Professionals; Webinars; CE Credits | Drug Regulatory Process; Drug Development; Generic Drugs; OTC Drug Regulations; Biosimilars; Drug Safety; MedWatch; IND; Disease States; Prescription Drug Promotion; Cancer Drugs |
Compounding Quality Center of Excellence On-Demand Training | CE Credits; Health Care Professionals; Case Study; Podcasts; Videos; Webinars | Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; MedWatch |
Additional Resources
- FDA Continuing Education Programs
- Training and Continuing Education
- FDA Learning Portal for Students, Academia, and Industry
- For questions contact CDER Division of Drug Information
Sub-Topic Paragraphs
Paragraph Header
Contact Us
Paragraph Header
Contact Us
Contact Point
Office of Communications
10001 New Hampshire Ave
Hillandale Building, 4th Fl
Silver Spring, MD 20993
10001 New Hampshire Ave
Hillandale Building, 4th Fl
Silver Spring, MD 20993
Toll Free
(855) 543-3784
(301) 796-3400
Hours Available
CDER Division of Drug Information
For Updates on Twitter follow
Contact Point Twitter
@FDA_Drug_Info
Your source for the latest drug information.
Know the moment it happens.